• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项多中心调查结果显示,神经外科医生在决定胶质母细胞瘤手术切除的激进程度时存在个体差异,这凸显了制定更客观指南的必要性。

Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.

作者信息

Capellades J, Teixidor P, Villalba G, Hostalot C, Plans G, Armengol R, Medrano S, Estival A, Luque R, Gonzalez S, Gil-Gil M, Villa S, Sepulveda J, García-Mosquera J J, Balana C

机构信息

Neuro-radiology Service, Hospital del Mar, 08003, Barcelona, Spain.

Neurosurgery Service, Hospital Universitari Germans Trias i Pujol, IGTP, 08916, Badalona, Spain.

出版信息

Clin Transl Oncol. 2017 Jun;19(6):727-734. doi: 10.1007/s12094-016-1598-6. Epub 2016 Dec 22.

DOI:10.1007/s12094-016-1598-6
PMID:28005261
Abstract

PURPOSE

We assessed agreement among neurosurgeons on surgical approaches to individual glioblastoma patients and between their approach and those recommended by the topographical staging system described by Shinoda.

METHODS

Five neurosurgeons were provided with pre-surgical MRIs of 76 patients. They selected the surgical approach [biopsy, partial resection, or gross total resection (GTR)] that they would recommend for each patient. They were blinded to each other's response and they were told that patients were younger than 50 years old and without symptoms. Three neuroradiologists classified each case according to the Shinoda staging system.

RESULTS

Biopsy was recommended in 35.5-82.9%, partial resection in 6.6-32.9%, and GTR in 3.9-31.6% of cases. Agreement among their responses was fair (global kappa = 0.28). Nineteen patients were classified as stage I, 14 as stage II, and 43 as stage III. Agreement between the neurosurgeons and the recommendations of the staging system was poor for stage I (kappa = 0.14) and stage II (kappa = 0.02) and fair for stage III patients (kappa = 0.29). An individual analysis revealed that in contrast to the Shinoda system, neurosurgeons took into account T2/FLAIR sequences and gave greater weight to the involvement of eloquent areas.

CONCLUSIONS

The surgical approach to glioblastoma is highly variable. A staging system could be used to examine the impact of extent of resection, monitor post-operative complications, and stratify patients in clinical trials. Our findings suggest that the Shinoda staging system could be improved by including T2/FLAIR sequences and a more adequate weighting of eloquent areas.

摘要

目的

我们评估了神经外科医生对个别胶质母细胞瘤患者手术入路的一致性,以及他们的入路与筱田所描述的地形学分期系统所推荐的入路之间的一致性。

方法

向五位神经外科医生提供了76例患者的术前磁共振成像(MRI)。他们选择了会为每位患者推荐的手术入路[活检、部分切除或全切除(GTR)]。他们对彼此的回答不知情,且被告知患者年龄小于50岁且无症状。三位神经放射科医生根据筱田分期系统对每个病例进行分类。

结果

35.5%-82.9%的病例推荐活检,6.6%-32.9%的病例推荐部分切除,3.9%-31.6%的病例推荐全切除。他们回答之间的一致性一般(总体kappa系数=0.28)。19例患者被分类为I期,14例为II期,43例为III期。神经外科医生与分期系统推荐之间的一致性在I期(kappa系数=0.14)和II期(kappa系数=0.02)较差,在III期患者中一般(kappa系数=0.29)。个体分析显示,与筱田系统不同,神经外科医生考虑了T2/液体衰减反转恢复(FLAIR)序列,并更重视功能区的受累情况。

结论

胶质母细胞瘤的手术入路差异很大。分期系统可用于研究切除范围的影响、监测术后并发症以及在临床试验中对患者进行分层。我们的研究结果表明,通过纳入T2/FLAIR序列和对功能区进行更适当的加权,筱田分期系统可以得到改进。

相似文献

1
Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.一项多中心调查结果显示,神经外科医生在决定胶质母细胞瘤手术切除的激进程度时存在个体差异,这凸显了制定更客观指南的必要性。
Clin Transl Oncol. 2017 Jun;19(6):727-734. doi: 10.1007/s12094-016-1598-6. Epub 2016 Dec 22.
2
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.术前影像学分期系统是否可用于提示胶质母细胞瘤的最佳切除范围并预测预后?一项观察性研究。
J Neurooncol. 2018 Apr;137(2):367-377. doi: 10.1007/s11060-017-2726-z. Epub 2017 Dec 28.
3
Evaluation of surgical decision making and resulting outcome in patients with highly eloquent glioblastoma: Results of a multicenter assessment.对高功能区胶质母细胞瘤患者手术决策及最终结果的评估:一项多中心评估结果
Clin Neurol Neurosurg. 2017 Nov;162:29-35. doi: 10.1016/j.clineuro.2017.09.006. Epub 2017 Sep 8.
4
Accuracy of the neurosurgeons estimation of extent of resection in glioblastoma.神经外科医生对胶质母细胞瘤切除程度估计的准确性。
Acta Neurochir (Wien). 2020 Feb;162(2):373-378. doi: 10.1007/s00701-019-04089-8. Epub 2019 Oct 28.
5
On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.在胶质母细胞瘤手术的前沿:神经外科医生在手术决策上的一致与分歧。
J Neurosurg. 2021 Jul 9;136(1):45-55. doi: 10.3171/2020.11.JNS202897. Print 2022 Jan 1.
6
Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.脑胶质瘤患者的切除术范围:限制因素、可切除性感知及其对生存的影响。
J Neurosurg. 2012 Nov;117(5):851-9. doi: 10.3171/2012.8.JNS12234. Epub 2012 Sep 14.
7
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.残留肿瘤体积与切除范围:胶质母细胞瘤手术后生存的预测因素
J Neurosurg. 2014 Nov;121(5):1115-23. doi: 10.3171/2014.7.JNS132449. Epub 2014 Sep 5.
8
When gross total resection of a glioblastoma is possible, how much resection should be achieved?当有可能进行胶质母细胞瘤的大体全切除时,应该达到多大的切除程度?
World Neurosurg. 2014 Jul-Aug;82(1-2):e257-65. doi: 10.1016/j.wneu.2014.01.019. Epub 2014 Feb 6.
9
Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note.使用高剂量荧光素钠进行多形性胶质母细胞瘤的荧光引导切除术。技术说明。
J Neurosurg. 2003 Sep;99(3):597-603. doi: 10.3171/jns.2003.99.3.0597.
10
Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.世界卫生组织二级星形细胞瘤全切除的效果:基于监测、流行病学和最终结果数据库的生存分析
World Neurosurg. 2017 Jul;103:741-747. doi: 10.1016/j.wneu.2017.03.140. Epub 2017 Apr 16.

引用本文的文献

1
Resection versus biopsy in patients with glioblastoma (RESBIOP study): study protocol for an international multicentre prospective cohort study (ENCRAM 2202).切除与活检在胶质母细胞瘤患者中的对比(RESBIOP 研究):一项国际多中心前瞻性队列研究(ENCRAM 2202)的研究方案。
BMJ Open. 2024 Sep 10;14(9):e081689. doi: 10.1136/bmjopen-2023-081689.
2
Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes.局限性低级别胶质瘤(cLGG)与浸润性低级别胶质瘤(iLGG)的新型分类建议:放射学特征与临床结果的相关性
World Neurosurg X. 2024 Mar 1;23:100356. doi: 10.1016/j.wnsx.2024.100356. eCollection 2024 Jul.
3

本文引用的文献

1
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.贝伐单抗联合替莫唑胺与单纯替莫唑胺作为新辅助治疗用于未切除的胶质母细胞瘤:GENOM 009随机II期试验
J Neurooncol. 2016 May;127(3):569-79. doi: 10.1007/s11060-016-2065-5. Epub 2016 Feb 3.
2
Pseudoprogression in glioblastoma patients: the impact of extent of resection.胶质母细胞瘤患者的假性进展:手术切除范围的影响。
J Neurooncol. 2016 Feb;126(3):559-66. doi: 10.1007/s11060-015-2001-0. Epub 2015 Nov 25.
3
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Preoperative assessment of eloquence in neurosurgery: a systematic review.
神经外科中的语言功能评估:系统综述。
J Neurooncol. 2023 Dec;165(3):413-430. doi: 10.1007/s11060-023-04509-x. Epub 2023 Dec 14.
4
Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort.胶质母细胞瘤的生存与肿瘤位置的关系:基于人群队列的统计肿瘤图谱
Acta Neurochir (Wien). 2021 Jul;163(7):1895-1905. doi: 10.1007/s00701-021-04802-6. Epub 2021 Mar 20.
5
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.术前影像学分期系统是否可用于提示胶质母细胞瘤的最佳切除范围并预测预后?一项观察性研究。
J Neurooncol. 2018 Apr;137(2):367-377. doi: 10.1007/s11060-017-2726-z. Epub 2017 Dec 28.
1229例胶质母细胞瘤患者最大安全切除对生存的影响:我们能否比全切除做得更好?
J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23.
4
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.残留肿瘤体积与切除范围:胶质母细胞瘤手术后生存的预测因素
J Neurosurg. 2014 Nov;121(5):1115-23. doi: 10.3171/2014.7.JNS132449. Epub 2014 Sep 5.
5
Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.重新探讨胶质母细胞瘤的切除术范围:个性化生存建模有助于更准确的生存预测,并支持以最大安全切除为手术方法。
J Clin Oncol. 2014 Mar 10;32(8):774-82. doi: 10.1200/JCO.2013.51.8886. Epub 2014 Feb 10.
6
An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.复发性胶质母细胞瘤的切除程度及其对神经发病率的风险。
J Neurosurg. 2014 Apr;120(4):846-53. doi: 10.3171/2013.12.JNS13184. Epub 2014 Jan 31.
7
Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.最大限度提高胶质母细胞瘤手术患者的切除范围和生存获益:高场强 iMRI 与常规及 5-ALA 辅助手术的比较。
Eur J Surg Oncol. 2014 Mar;40(3):297-304. doi: 10.1016/j.ejso.2013.11.022. Epub 2013 Dec 19.
8
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.确定影响新诊断颅内胶质母细胞瘤患者生存和复发的百分比切除率和残余体积阈值。
Neuro Oncol. 2014 Jan;16(1):113-22. doi: 10.1093/neuonc/not137. Epub 2013 Nov 26.
9
Operability of glioblastomas: "sins of action" versus "sins of non-action".脑胶质瘤的可操作性:“行动之罪”与“不作为之罪”。
Neurol Sci. 2013 Dec;34(12):2107-16. doi: 10.1007/s10072-013-1345-5. Epub 2013 Mar 12.
10
Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis.术中刺激脑图谱对胶质瘤手术结果的影响:荟萃分析。
J Clin Oncol. 2012 Jul 10;30(20):2559-65. doi: 10.1200/JCO.2011.38.4818. Epub 2012 Apr 23.